Quantcast

Latest Prasugrel Stories

2009-11-15 07:00:00

ORLANDO, Fla., Nov. 15 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced results of a PLATO sub-analysis in the most serious type of Acute Coronary Syndrome (ACS) patients, those with ST Segment Elevation Myocardial Infarction (STEMI).

2009-11-15 07:00:00

Study highlights: - A new reversible, intravenous blood thinner did not show superiority over an irreversible one currently approved for use. - Further investigation of the new anti-clotting drug is warranted. ORLANDO, Fla., Nov.

2009-10-20 06:00:00

FRANKLIN LAKES, N.J., Oct. 20 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc.

2009-09-24 14:10:00

SAN FRANCISCO, Sept. 24 /PRNewswire-FirstCall/ -- New data from the phase III PLATO study showed that ticagrelor (BRILINTA((TM))) provided greater reduction of cardiovascular (CV) events (composite of CV death, heart attack and stroke) than clopidogrel (9.02% vs.

2009-09-02 07:30:00

SAN DIEGO, Sept. 2 /PRNewswire/ -- Accumetrics, Inc. has announced the signing of a new exclusive distribution agreement for its VerifyNow(R) System in Spain, Portugal and Chile with Grifols S.A..

2009-08-31 09:43:16

Studies from a growing body of convincing data show that responsiveness to antiplatelet therapy is real. This is a clinically important issue and there is a need to develop individual antiplatelet strategies particularly for patients at risk.

2009-08-31 08:43:55

Data from a phase II trial of an investigational intravenous drug designed to block the formation of blood clots shows potential to reduce the risk of death, a second heart attack, or other coronary complications compared with the current standard of care in patients presenting with acute coronary syndromes (heart attacks or unstable angina).


Word of the Day
shavie
  • A trick or prank.
The word 'shavie' is related to 'shave'.